Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 3/20 | 0.55 |
| ▸ | CA2 | P00918 | 3/20 | 0.55 |
| ▸ | CA7 | P43166 | 2/20 | 0.55 |
| ▸ | CA9 | Q16790 | 2/20 | 0.55 |
| ▸ | CA12 | O43570 | 1/20 | 0.55 |
| ▸ | CA4 | P22748 | 1/20 | 0.55 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.44 |
| ▸ | TP53 | P04637 | 2/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.44 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.41 |
| ▸ | ORAI1 | Q96D31 | 1/20 | 0.40 |
| ▸ | ORAI2 | Q96SN7 | 1/20 | 0.40 |
| ▸ | ORAI3 | Q9BRQ5 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30837263 | 1.00 | CA1 (0.55) | CA1CA2CA7CA9CA12 | |
| SCHEMBL889796 | 0.86 | CA1 (0.55) | CA1CA2CA7CA9CA12 | |
| SCHEMBL50148 | 0.80 | CA1 (0.60) | CA1CA2CA7CA9CA12 | |
| SCHEMBL10414766 | 0.80 | CA1 (0.60) | CA1CA2CA7CA9CA12 | |
| SCHEMBL29405044 | 0.80 | CA1 (0.60) | CA1CA2CA7CA9CA12 | |
| SCHEMBL2154356 | 0.79 | CA1 (0.46) | CA1CA2CA7CA9CA12 | |
| SCHEMBL28888547 | 0.79 | CA1 (0.46) | CA1CA2CA7CA9CA12 | |
| SCHEMBL8419557 | 0.78 | CA1 (0.57) | CA1CA2CA7CA9CA12 | |
| Hydrochloric Acid SCHEMBL7972166 | 0.78 | CA1 (0.57) | CA1CA2CA7CA9CA12 | |
| SCHEMBL15658840 | 0.78 | CA1 (0.57) | CA1CA2CA7CA9CA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 58 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3853172-B1 | METHODS FOR PREPARING ARYLPHOSPHINE-BORANE COMPLEXES | DOW GLOBAL TECHNOLOGIES LLC (US) | 2023-07-05 | — | — | EP | claimed |
| US-20210380613-A1 | METHODS FOR PREPARING ARYLPHOSPHINE-BORANE COMPLEXES | DOW GLOBAL TECHNOLOGIES LLC (US) | 2021-12-09 | — | — | US | claimed |
| EP-3853172-A1 | METHODS FOR PREPARING ARYLPHOSPHINE-BORANE COMPLEXES | Dow Global Technologies LLC (US) | 2021-07-28 | — | — | EP | claimed |
| WO-2020061151-A1 | METHODS FOR PREPARING ARYLPHOSPHINE-BORANE COMPLEXES | DOW GLOBAL TECHNOLOGIES LLC (US) | 2020-03-26 | — | — | WO | claimed |
| EP-1354886-B1 | Process for the preparation of tertiary phosphines | SALTIGO GMBH (DE) | 2009-08-26 | — | — | EP | claimed |
| US-7230136-B2 | Reacting phosphorus halide with organomagnesium compound in presence of copper compound | LANXESS DEUTSCHLAND GMBH (DE) | 2007-06-12 | — | — | US | claimed |
| EP-1598053-B1 | Use of a composition containing at least one phosphine as majority reducing agent to remove the artificial colour of keratinic fibres | OREAL (FR) | 2006-12-20 | — | — | EP | claimed |
| EP-1598053-A1 | Use of a composition containing at least one phosphine as majority reducing agent to remove the artificial colour of keratinic fibres | L'OREAL (FR) | 2005-11-23 | — | — | EP | claimed |
| US-20050251928-A1 | Method for stripping artificial color from keratin fibers | L'OREAL (FR) | 2005-11-17 | — | — | US | claimed |
| US-20030229240-A1 | Reacting phosphorus halide with organomagnesium compound in presence of copper compound | LANXESS DEUTSCHLAND GMBH (DE) | 2003-12-11 | — | — | US | claimed |
| EP-1354886-A1 | Process for the preparation of tertiary phosphines | Bayer Aktiengesellschaft (DE) | 2003-10-22 | — | — | EP | claimed |
| EP-3853172-B1 | METHODS FOR PREPARING ARYLPHOSPHINE-BORANE COMPLEXES | DOW GLOBAL TECHNOLOGIES LLC (US) | 2023-07-05 | — | — | EP | disclosed |
| US-20230165771-A1 | PROCESS FOR TREATING KERATIN FIBERS USING PARTICULAR AMINO ACIDS IN HIGH CONCENTRATION | L'OREAL (FR) | 2023-06-01 | — | — | US | disclosed |
| EP-4171490-A1 | PROCESS FOR TREATING KERATIN FIBERS USING PARTICULAR AMINO ACIDS IN HIGH CONCENTRATION | L'OREAL (FR) | 2023-05-03 | — | — | EP | disclosed |
| WO-2022003040-A1 | PROCESS FOR TREATING KERATIN FIBERS USING PARTICULAR AMINO ACIDS IN HIGH CONCENTRATION | L'OREAL (FR) | 2022-01-06 | — | — | WO | disclosed |
| US-4952728-A | OPTICALLY ACTIVE | SOCIETE NATIONALE ELF AQUITAINE (FR) | 1990-08-28 | — | — | US | disclosed |
| EP-0115945-B1 | SYNTHESIS OF HIGH MOLECULAR WEIGHT POLYBENZIMIDAZOLES | CELANESE CORPORATION (US) | 1988-11-30 | — | — | EP | disclosed |
| US-4535144-A | AMINOARYL ESTER REACTANT, TWO-STAGE MELT POLYMERIZATION | CELANESE CORPORATION (US) | 1985-08-13 | — | — | US | disclosed |
| US-4533725-A | BY-PRODUCT INHIBITION; HEATING A FOAMED PREPOLYMER | DELANESE CORPORATION (US) | 1985-08-06 | — | — | US | disclosed |
| EP-0115945-A2 | Synthesis of high molecular weight polybenzimidazoles | CELANESE CORPORATION (US) | 1984-08-15 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230165771-A1 | PROCESS FOR TREATING KERATIN FIBERS USING PARTICULAR AMINO ACIDS IN HIGH CONCENTRATION | KRT18, CKAP4, VIM | CA1 1100/4885CA2 1216/4885CA7 1308/4885 |
| US-20050251928-A1 | Method for stripping artificial color from keratin fibers | KRT18, DSG1, JUP | CA1 311/4885CA2 223/4885CA7 70/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.